Publication dates

All regions

Ovarian Cancer Industry, July 2014 Market Reports from Top Publishers

You might be interested in: cancer, therapeutics, medical equipment, more »


 
1-20 of about 5 900 reports for Ovarian Cancer

Ovarian Cancer Drug Pipeline Update 2014

Ovarian Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... There are 8 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 96 drugs. ovarian cancer drug pipeline update lists all drugs and gives you a progress analysis ...

Ovarian Cancer Drug Pathway Analyzer 2014

Ovarian Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... To your pipeline specifications3. Compare - you can overlay any pathways with each other and do a comparative analysisyou can interactively analyze any ovarian cancer drug ...

AIDS - Related Kaposi%s Sarcoma - Pipeline Review, H2 2014

AIDS - Related Kaposi%s Sarcoma - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • July 2014
  • by Global Markets Direct

... Of ontak, targretin and panretin 54apr 15, 1999: supplemental nda for alza's doxil in refractory ovarian cancer granted priority review. 54Mar 30, 1999: ligand and fer entered into agreement ...

Epithelial Ovarian Cancer - Pipeline Review, H2 2014

Epithelial Ovarian Cancer - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • July 2014
  • by Global Markets Direct

... ovarian cancer pipeline on the basis of target, moa, route of administration and molecule type- latest news and deals relating related to pipeline productsreasons to buy- provides ...

Global Women%s Health Market 2014-2018

Global Women%s Health Market 2014-2018

  • $ 2 500
  • Industry report
  • July 2014
  • by Infiniti Research Limited

... And polycystic ovarian syndrome as well as urological disorders and cancers such as breast cancer, cervical cancer, endometrial cancer, and ovarian cancer. In addition, contraception plays an important role ...

 Metastatic Ovarian Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Metastatic Ovarian Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Evaluate the marketing status and exclusivity details of metastatic ovarian cancer key products to exploit opportunities for generic drug development opportunities. - Identify and understand important ...

Becton, Dickinson and Company (BDX) - Product Pipeline Analysis, 2014 Update

Becton, Dickinson and Company (BDX) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

... Status 29diagnostic test - breast cancer - product description 29diagnostic test - ovarian cancer - product status 30diagnostic test - ovarian cancer - product description 30dx mini ...

AnalizaDx, LLC - Product Pipeline Analysis, 2014 Update

AnalizaDx, LLC - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

... Biomarker assay - ovarian cancer product overview 12biomarker assay - pancreatic cancer 13biomarker assay - pancreatic cancer product overview 13biomarker assay - prostate cancer 14 ...

Pronota NV - Product Pipeline Analysis, 2014 Update

Pronota NV - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

... Kidney function - product description 15diagnostic test - ovarian cancer - product status 16diagnostic test - ovarian cancer - product description 16diagnostic test - pre-eclampsia - product ...

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • June 2014
  • by Global Data

... And diagnostic products. Its products include cr0014, ovplex, and clear it. Healthlinx's cr014 is an inhibitor of vascular leak; ovplex is a multimarker blood test for ovarian cancer; and clear it is a protein ...

About 1 100 reports for Ovarian Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • Disease State Primer: Ovarian Cancer
  • January 2012
    8 pages
  • Ovarian Cancer  

    Cancer  

  • United States  

    World  

    North America  

View report >

1 Companies for Ovarian Cancer

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.